K. Nonogaki et al., LIF AND CNTF, WHICH SHARE THE GP130 TRANSDUCTION SYSTEM, STIMULATE HEPATIC LIPID-METABOLISM IN RATS, American journal of physiology: endocrinology and metabolism, 34(3), 1996, pp. 521-528
We determined the effects of leukemia inhibitory factor (LIF) and cili
ary neurotrophic factor (CNTF) on lipid metabolism in intact rats. Adm
inistration of LIF and CNTF increased serum triglycerides in a dose-de
pendent manner with peak values at 2 h. The effects of LIF and CNTF on
serum cholesterol were very small, and serum glucose was unaffected.
Both LIF and CNTF stimulated hepatic triglyceride secretion, hepatic d
e novo fatty acid synthesis, and lipolysis. Pretreatment with phenylis
opropyl adenosine, which inhibits lipolysis, partially inhibited LIF-
and CNTF-induced hypertriglyceridemia. Interleukin-4, which inhibits c
ytokine-induced hepatic fatty acid synthesis, also partially inhibited
LIF- and CNTF-induced hypertriglyceridemia. These results indicate th
at both lipolysis and de novo fatty acid synthesis play a role in prov
iding fatty acids for the increase in hepatic triglyceride secretion.
Neither indomethacin nor adrenergic receptor antagonists affected the
hypertriglyceridemia. The combination of LIF plus CNTF showed no addit
ive effects consistent with the action of both cytokines through the g
p130 transduction system. Thus LIF and CNTF have similar effects on li
pid metabolism; they join a growing list of cytokines that stimulate h
epatic triglyceride secretion and may mediate the changes in lipid met
abolism that accompany the acute phase response.